These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4964920)

  • 1. [Effects of temperature and period of preservation of resistant media on minimal inhibitory concentration of alpha-ethyl-thioisonicotinamide (1314 th) to the growth of Mycobacterium tuberculosis].
    Tamura M; Yamazaki A
    Kekkaku; 1967 May; 42(5):165-72. PubMed ID: 4964920
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of preservation temperature and period of media used for drug sensitivity test on minimal inhibitory concentration of D-ethambutol to the growth of mycobacterium tuberculosis].
    Tamura M; Takano S
    Kekkaku; 1969 Feb; 44(2):41-7. PubMed ID: 4977197
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the 1314TH resistant media].
    Hayashi N; Inada S; Kobayashi H; Hara M; Yamagiwa N
    Iryo; 1969 Feb; 23(2):179-82. PubMed ID: 4979517
    [No Abstract]   [Full Text] [Related]  

  • 4. [Conditions for ethionamide activity and the formation of resistant Mycobacterium tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1979 Oct; (10):58-60. PubMed ID: 41236
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison between antituberculous activity of alpha-ethyl-thioisonicotinamide (1314 TH) and alpha-N-propylthioisonicotinamide (1321 TH) in vitro].
    Tamura M; Takano S
    Kekkaku; 1971 May; 46(5):137-52. PubMed ID: 4996120
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antituberculous action and clinical effects of alpha-propyl-thioisonicotinamide (1321 TH)].
    Yamamoto K; Sakurai H; Inoue I; Sasaoka M; Hashimoto T
    Saishin Igaku; 1967 Sep; 22(9):2087-97. PubMed ID: 4966177
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new method of cultivating Mycobacterium tuberculosis].
    Bil'ko IP; Klimenko MT
    Vrach Delo; 1991 Feb; (2):95-7. PubMed ID: 1905435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental and clinical evaluation of alpha-propyl-2-thioisonicotinamide (1321 TH)].
    Kawamori U; Soejima R; Tagawa K; Nagao T; Nozute H
    Saishin Igaku; 1967 Sep; 22(9):2066-72. PubMed ID: 4966175
    [No Abstract]   [Full Text] [Related]  

  • 10. Dilemmas and realities in the laboratory diagnosis of tuberculosis in low income countries.
    Heifets L; Lindholm-Levy P
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):88-9. PubMed ID: 10091872
    [No Abstract]   [Full Text] [Related]  

  • 11. The ethionamide sensitivity of East African strains of Mycobacterium tuberculosis resistant to thiacetazone.
    Lefford MJ
    Tubercle; 1969 Mar; 50(1):7-13. PubMed ID: 4181091
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new method for measuring the resistance of mycobacteria].
    Bretey J
    Bull Acad Natl Med; 1970; 154(5):95-100. PubMed ID: 4987238
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)].
    Hayashi S
    Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of methods for testing the sensitivity of Mycobacterium tuberculosis to ethionamide.
    Lefford MJ; Mitchison DA
    Tubercle; 1966 Sep; 47(3):250-61. PubMed ID: 4961602
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide.
    Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
    J Antimicrob Chemother; 2004 Apr; 53(4):600-3. PubMed ID: 14973155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Criteria of mycobacterium resistance to thioacetazone and cross resistance to ethionamide].
    Afanas'eva IuP; Mkrtchian SV
    Probl Tuberk; 1969; 47(3):66-9. PubMed ID: 4982181
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ways of increasing inoculation and growth acceleration of Mycobacterium tuberculosis].
    Finn ER
    Probl Tuberk; 1974; (12):72-5. PubMed ID: 4216899
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the instability of ethionamide resistance and on the stability of other drug resistances in tubercle bacilli (five to nine years' in vitro observations)].
    Tsukamura M; Tsukamura S
    Kekkaku; 1967 Jan; 42(1):23-7. PubMed ID: 4962455
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies in guinea pigs on the resistance of tubercle bacilli to ethionamide].
    Janowiec M; Krakówka P
    Gruzlica; 1965 Apr; 33(4):273-6. PubMed ID: 4953732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.